chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Influenza like illness, Migraine, Myalgia, Oropharyngeal pain, Pyrexia
Clinical narrative: Slight stomach ache; Loss of appetite; Sore muscles; Chills; Feverish; Very tired and still tired and blah 5 days post shot; Swollen lymph nodes under left armpit; Sore throat; Bad flu like symptoms for two days post shot; Could not get a good sleep; Migraine starting about one hour post shot lasting for 2 days and on and off for up to 5 days; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the right arm on 07Jul2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea, high blood pressure (bp), high cholesterol, gastroesophageal reflux disease (GERD) and asthma. The patient had known allergies to eggs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN), montelukast (MANUFACTURER UNKNOWN) and rosuvastatin calcium (ROSUVASTIN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 17Jun2021 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Jul2021 at 16:00, about one hour post shot, the patient experienced migraine lasting for two days and on and off for up to five days. On 07Jul2021 at 16:30, the patient experienced very tired, sore throat, sore muscles, bad flu like symptoms for two days post shot, loss of appetite, could not get out of bed as so tired but could not get a good sleep, chills and feverish, swollen lymph nodes under left armpit. On 08Jul2021, second day post shot, the patient also had a slight stomach ache. On 12Jul2021, five days post shot, the patient still felt tired and had to take days off of work. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu like symptoms was recovered with sequelae on 09Jul2021, after the duration of 2 days; while that of the migraine was recovered with sequelae on 12Jul2021, after the duration of 5 days. The clinical outcome of the events sore throat, poor sleep, loss of appetite, sore muscles, chills, feverish, tiredness, swollen lymph nodes, stomach ache was recovered with sequelae on an unknown date in Jul2021.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder
Clinical narrative: Slight stomach ache; Loss of appetite; Sore muscles; Chills; Feverish; Very tired and still tired and blah 5 days post shot; Swollen lymph nodes under left armpit; Sore throat; Bad flu like symptoms for two days post shot; Could not get a good sleep; Migraine starting about one hour post shot lasting for 2 days and on and off for up to 5 days; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the right arm on 07Jul2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea, high blood pressure (bp), high cholesterol, gastroesophageal reflux disease (GERD) and asthma. The patient had known allergies to eggs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN), montelukast (MANUFACTURER UNKNOWN) and rosuvastatin calcium (ROSUVASTIN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 17Jun2021 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Jul2021 at 16:00, about one hour post shot, the patient experienced migraine lasting for two days and on and off for up to five days. On 07Jul2021 at 16:30, the patient experienced very tired, sore throat, sore muscles, bad flu like symptoms for two days post shot, loss of appetite, could not get out of bed as so tired but could not get a good sleep, chills and feverish, swollen lymph nodes under left armpit. On 08Jul2021, second day post shot, the patient also had a slight stomach ache. On 12Jul2021, five days post shot, the patient still felt tired and had to take days off of work. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu like symptoms was recovered with sequelae on 09Jul2021, after the duration of 2 days; while that of the migraine was recovered with sequelae on 12Jul2021, after the duration of 5 days. The clinical outcome of the events sore throat, poor sleep, loss of appetite, sore muscles, chills, feverish, tiredness, swollen lymph nodes, stomach ache was recovered with sequelae on an unknown date in Jul2021.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chills, Decreased appetite, Fatigue, Influenza like illness
Clinical narrative: Slight stomach ache; Loss of appetite; Sore muscles; Chills; Feverish; Very tired and still tired and blah 5 days post shot; Swollen lymph nodes under left armpit; Sore throat; Bad flu like symptoms for two days post shot; Could not get a good sleep; Migraine starting about one hour post shot lasting for 2 days and on and off for up to 5 days; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the right arm on 07Jul2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea, high blood pressure (bp), high cholesterol, gastroesophageal reflux disease (GERD) and asthma. The patient had known allergies to eggs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN), montelukast (MANUFACTURER UNKNOWN) and rosuvastatin calcium (ROSUVASTIN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 17Jun2021 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Jul2021 at 16:00, about one hour post shot, the patient experienced migraine lasting for two days and on and off for up to five days. On 07Jul2021 at 16:30, the patient experienced very tired, sore throat, sore muscles, bad flu like symptoms for two days post shot, loss of appetite, could not get out of bed as so tired but could not get a good sleep, chills and feverish, swollen lymph nodes under left armpit. On 08Jul2021, second day post shot, the patient also had a slight stomach ache. On 12Jul2021, five days post shot, the patient still felt tired and had to take days off of work. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu like symptoms was recovered with sequelae on 09Jul2021, after the duration of 2 days; while that of the migraine was recovered with sequelae on 12Jul2021, after the duration of 5 days. The clinical outcome of the events sore throat, poor sleep, loss of appetite, sore muscles, chills, feverish, tiredness, swollen lymph nodes, stomach ache was recovered with sequelae on an unknown date in Jul2021.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Migraine, Myalgia, Oropharyngeal pain, Poor quality sleep
Clinical narrative: Slight stomach ache; Loss of appetite; Sore muscles; Chills; Feverish; Very tired and still tired and blah 5 days post shot; Swollen lymph nodes under left armpit; Sore throat; Bad flu like symptoms for two days post shot; Could not get a good sleep; Migraine starting about one hour post shot lasting for 2 days and on and off for up to 5 days; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the right arm on 07Jul2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea, high blood pressure (bp), high cholesterol, gastroesophageal reflux disease (GERD) and asthma. The patient had known allergies to eggs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN), montelukast (MANUFACTURER UNKNOWN) and rosuvastatin calcium (ROSUVASTIN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 17Jun2021 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Jul2021 at 16:00, about one hour post shot, the patient experienced migraine lasting for two days and on and off for up to five days. On 07Jul2021 at 16:30, the patient experienced very tired, sore throat, sore muscles, bad flu like symptoms for two days post shot, loss of appetite, could not get out of bed as so tired but could not get a good sleep, chills and feverish, swollen lymph nodes under left armpit. On 08Jul2021, second day post shot, the patient also had a slight stomach ache. On 12Jul2021, five days post shot, the patient still felt tired and had to take days off of work. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu like symptoms was recovered with sequelae on 09Jul2021, after the duration of 2 days; while that of the migraine was recovered with sequelae on 12Jul2021, after the duration of 5 days. The clinical outcome of the events sore throat, poor sleep, loss of appetite, sore muscles, chills, feverish, tiredness, swollen lymph nodes, stomach ache was recovered with sequelae on an unknown date in Jul2021.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Slight stomach ache; Loss of appetite; Sore muscles; Chills; Feverish; Very tired and still tired and blah 5 days post shot; Swollen lymph nodes under left armpit; Sore throat; Bad flu like symptoms for two days post shot; Could not get a good sleep; Migraine starting about one hour post shot lasting for 2 days and on and off for up to 5 days; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the right arm on 07Jul2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea, high blood pressure (bp), high cholesterol, gastroesophageal reflux disease (GERD) and asthma. The patient had known allergies to eggs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN), montelukast (MANUFACTURER UNKNOWN) and rosuvastatin calcium (ROSUVASTIN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 17Jun2021 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Jul2021 at 16:00, about one hour post shot, the patient experienced migraine lasting for two days and on and off for up to five days. On 07Jul2021 at 16:30, the patient experienced very tired, sore throat, sore muscles, bad flu like symptoms for two days post shot, loss of appetite, could not get out of bed as so tired but could not get a good sleep, chills and feverish, swollen lymph nodes under left armpit. On 08Jul2021, second day post shot, the patient also had a slight stomach ache. On 12Jul2021, five days post shot, the patient still felt tired and had to take days off of work. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu like symptoms was recovered with sequelae on 09Jul2021, after the duration of 2 days; while that of the migraine was recovered with sequelae on 12Jul2021, after the duration of 5 days. The clinical outcome of the events sore throat, poor sleep, loss of appetite, sore muscles, chills, feverish, tiredness, swollen lymph nodes, stomach ache was recovered with sequelae on an unknown date in Jul2021.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye swelling, Swelling face, Swelling of eyelid
Clinical narrative: The swelling then spread to the leftside of my face and lips.; Two days after my second vaccine Ihad intense swelling under my left eye.The swelling then spread to the left side of my face and lips.There is still swelling under my left eye , to the left side of my nose, lowereye and upper left eyelid.Its painful; Had intense swelling under my left eye. The swelling then spread to the left side of my face and lips. There is still swelling under my left eye , to the left side of my nose, lower eye and upper left eyelid.Its painful.; The swelling then spread to the leftside of my face and lips.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Jul2021 at 15:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issue. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Jun2021 at 13:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. On 05Jul2021 at 04:45, two days after second vaccine, the patient had intense swelling under left eye, the swelling then spread to the left side of face and lips, there was still swelling under left eye, to the left side of nose, lower eye and upper left eyelid and it was painful. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the patient had intense swelling under left eye, the swelling then spread to the left side of face and lips, there was still swelling under left eye, to the left side of nose, lower eye and upper left eyelid and it was painful which included treatment with Benadryl and prednisone. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense swelling under left eye, the swelling then spread to the left side of face and lips, there was still swelling under left eye, to the left side of nose, lower eye and upper left eyelid and it was painful was not recovered at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Facial pain, Lip swelling, Periorbital swelling, Swelling face
Clinical narrative: The swelling then spread to the leftside of my face and lips.; Two days after my second vaccine Ihad intense swelling under my left eye.The swelling then spread to the left side of my face and lips.There is still swelling under my left eye , to the left side of my nose, lowereye and upper left eyelid.Its painful; Had intense swelling under my left eye. The swelling then spread to the left side of my face and lips. There is still swelling under my left eye , to the left side of my nose, lower eye and upper left eyelid.Its painful.; The swelling then spread to the leftside of my face and lips.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Jul2021 at 15:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issue. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Jun2021 at 13:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. On 05Jul2021 at 04:45, two days after second vaccine, the patient had intense swelling under left eye, the swelling then spread to the left side of face and lips, there was still swelling under left eye, to the left side of nose, lower eye and upper left eyelid and it was painful. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the patient had intense swelling under left eye, the swelling then spread to the left side of face and lips, there was still swelling under left eye, to the left side of nose, lower eye and upper left eyelid and it was painful which included treatment with Benadryl and prednisone. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense swelling under left eye, the swelling then spread to the left side of face and lips, there was still swelling under left eye, to the left side of nose, lower eye and upper left eyelid and it was painful was not recovered at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Hypoaesthesia, Neck pain, Paraesthesia
Clinical narrative: last 3 fingers in right hand went numb/ numbness in hand; pain in lower neck; pain in shoulder area; tingling and numbness in hand.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 04May2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant past medical history and no known allergies to medications, food or other products. Concomitant medication included tamoxifen (TAMOXIFENE); taken for unknown indication on unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021, the day after the shot the patient experienced pain in lower neck and shoulder area and on 09May2021, 5 days later the last 3 fingers in right hand went numb. The pain was controlled with prescriptions, but later on an unknown date in May2021 pain returned and she had continued tingling and numbness in hand. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included unspecified prescription medicine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome events pain in lower neck, pain in shoulder area, last 3 fingers in right hand went numb/ numbness in hand and tingling in fingers and hands was not recovered. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the left arm on 25May2021 as a single dose for COVID-19 immunisation.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Neck pain
Clinical narrative: last 3 fingers in right hand went numb/ numbness in hand; pain in lower neck; pain in shoulder area; tingling and numbness in hand.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 04May2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant past medical history and no known allergies to medications, food or other products. Concomitant medication included tamoxifen (TAMOXIFENE); taken for unknown indication on unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021, the day after the shot the patient experienced pain in lower neck and shoulder area and on 09May2021, 5 days later the last 3 fingers in right hand went numb. The pain was controlled with prescriptions, but later on an unknown date in May2021 pain returned and she had continued tingling and numbness in hand. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included unspecified prescription medicine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome events pain in lower neck, pain in shoulder area, last 3 fingers in right hand went numb/ numbness in hand and tingling in fingers and hands was not recovered. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the left arm on 25May2021 as a single dose for COVID-19 immunisation.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Muscle twitching
Clinical narrative: Random muscle twitching in arms, legs, fingers and toes; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration on 18May2021 at 14:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient had no known allergies reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in right arm on 27Apr2021 at 14:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 29Jun2021, the patient experienced random muscle twitching in arms, legs, fingers and toes. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event random muscle twitching in arms, legs, fingers and toes was not recovered at the time of this report.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle twitching
Clinical narrative: Random muscle twitching in arms, legs, fingers and toes; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration on 18May2021 at 14:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient had no known allergies reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in right arm on 27Apr2021 at 14:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 29Jun2021, the patient experienced random muscle twitching in arms, legs, fingers and toes. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event random muscle twitching in arms, legs, fingers and toes was not recovered at the time of this report.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Dyspnoea, Magnetic resonance imaging, Nerve conduction studies, Pain in extremity
Clinical narrative: 10 days after my first dose, I had ongoing pins and needles and numbness in my arms, legs, hands,and feet; 10 days after my first dose, I had ongoing pins and needles and numbness in my arms, legs, hands,and feet; numbness in my tongue and around my lips.; Severe shortness of breath; respiratory issues; This is a spontaneous report from a contactable consumer. A 52-years-old non-pregnant female patient received BNT162B2 (Formulation: Solution for injection; (Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 11Apr2021 11:15 AM as DOSE 1, SINGLE for covid-19 immunisation. Medical history included thyroid from an unknown date and unknown if ongoing. Not known allergies. Concomitant medication included levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 21Apr2021 18:00 PM patient experienced 10 days after my first dose, I had ongoing pins and needles and numbness in my arms, legs, hands, and feet. One week after that, numbness in my tongue and around my lips. Severe shortness of breath and respiratory issues are ongoing. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received treatment and that have not worked at all. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures which included Nasal Swab: negative on an unspecified date of Jun2021. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Paraesthesia oral, Peripheral swelling, Pyrexia, Respiratory disorder
Clinical narrative: 10 days after my first dose, I had ongoing pins and needles and numbness in my arms, legs, hands,and feet; 10 days after my first dose, I had ongoing pins and needles and numbness in my arms, legs, hands,and feet; numbness in my tongue and around my lips.; Severe shortness of breath; respiratory issues; This is a spontaneous report from a contactable consumer. A 52-years-old non-pregnant female patient received BNT162B2 (Formulation: Solution for injection; (Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 11Apr2021 11:15 AM as DOSE 1, SINGLE for covid-19 immunisation. Medical history included thyroid from an unknown date and unknown if ongoing. Not known allergies. Concomitant medication included levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 21Apr2021 18:00 PM patient experienced 10 days after my first dose, I had ongoing pins and needles and numbness in my arms, legs, hands, and feet. One week after that, numbness in my tongue and around my lips. Severe shortness of breath and respiratory issues are ongoing. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received treatment and that have not worked at all. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures which included Nasal Swab: negative on an unspecified date of Jun2021. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Hypoaesthesia, Hypoaesthesia oral, Paraesthesia, Respiratory disorder
Clinical narrative: 10 days after my first dose, I had ongoing pins and needles and numbness in my arms, legs, hands,and feet; 10 days after my first dose, I had ongoing pins and needles and numbness in my arms, legs, hands,and feet; numbness in my tongue and around my lips.; Severe shortness of breath; respiratory issues; This is a spontaneous report from a contactable consumer. A 52-years-old non-pregnant female patient received BNT162B2 (Formulation: Solution for injection; (Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 11Apr2021 11:15 AM as DOSE 1, SINGLE for covid-19 immunisation. Medical history included thyroid from an unknown date and unknown if ongoing. Not known allergies. Concomitant medication included levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 21Apr2021 18:00 PM patient experienced 10 days after my first dose, I had ongoing pins and needles and numbness in my arms, legs, hands, and feet. One week after that, numbness in my tongue and around my lips. Severe shortness of breath and respiratory issues are ongoing. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received treatment and that have not worked at all. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures which included Nasal Swab: negative on an unspecified date of Jun2021. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: 10 days after my first dose, I had ongoing pins and needles and numbness in my arms, legs, hands,and feet; 10 days after my first dose, I had ongoing pins and needles and numbness in my arms, legs, hands,and feet; numbness in my tongue and around my lips.; Severe shortness of breath; respiratory issues; This is a spontaneous report from a contactable consumer. A 52-years-old non-pregnant female patient received BNT162B2 (Formulation: Solution for injection; (Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 11Apr2021 11:15 AM as DOSE 1, SINGLE for covid-19 immunisation. Medical history included thyroid from an unknown date and unknown if ongoing. Not known allergies. Concomitant medication included levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 21Apr2021 18:00 PM patient experienced 10 days after my first dose, I had ongoing pins and needles and numbness in my arms, legs, hands, and feet. One week after that, numbness in my tongue and around my lips. Severe shortness of breath and respiratory issues are ongoing. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received treatment and that have not worked at all. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures which included Nasal Swab: negative on an unspecified date of Jun2021. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: Diagnosed me with shingles; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Jul2021 at 18:15 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history included lupus syndrome, anemia, arthritis, migraine, asthma, allergies and Hashimoto's thyroiditis. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Jul2021 at 12:00, four days after receiving first dose, the patient began to feel bad skin pain in the left side of body. Six days after receiving it began to break out in hives on that left side of body. Doctor diagnosed it as shingles. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event and included treatment with acyclovir (MANUFACTURER UNKNOWN) and tramadol (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event diagnosed with shingles was recovering at the time of this report.   The lot number for BNT162b2, were not provided and will be requested during follow up.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Chest scan, Chills, Fear of disease, Fibrin D dimer
Clinical narrative: 9 days later after second dose, severe chest pain returned and full body; and full body pains and aches.; Rheumatologist diagnosed as post viral immune syndrome related to covid vaccine.; Have numbness in left arm; slow reflexes; and ongoing pain in chest/neck and back; and ongoing pain in chest/neck and back; This is a spontaneous report from a contactable consumer (Patient). A 38-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8735), dose 2 via an unspecified route of administration, administered in Arm Left on 29Mar2021 (Age at vaccination: 38 years) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. Patient did not receive any other vaccines in 4 weeks. Patient did not receive other medications in 2 weeks. The patient was sensitive to estrogen birth controls. The patient experienced 9 days later after second dose, severe chest pain returned and full body and full body pains and aches, rheumatologist diagnosed as post viral immune syndrome related to covid vaccine, have numbness in left arm, slow reflexes, and ongoing pain in chest/neck and back on 07Apr2021. It was reported that 9 days later after second dose, severe chest pain returned and full body pains and aches. Rheumatologist diagnosed as post viral immune syndrome related to covid vaccine. Have numbness in left arm/slow reflexes and ongoing pain in chest/neck and back. Adverse events resulted in: Emergency room/department or urgent care. 2x physical therapy was given as treatment for the events. Patient did not have COVID prior vaccination. COVID tests post vaccination was unknown. The outcome of the events was not recovered.  Follow-up (23Aug2021): Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer increased, Pyrexia, Viral infection
Clinical narrative: 9 days later after second dose, severe chest pain returned and full body; and full body pains and aches.; Rheumatologist diagnosed as post viral immune syndrome related to covid vaccine.; Have numbness in left arm; slow reflexes; and ongoing pain in chest/neck and back; and ongoing pain in chest/neck and back; This is a spontaneous report from a contactable consumer (Patient). A 38-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8735), dose 2 via an unspecified route of administration, administered in Arm Left on 29Mar2021 (Age at vaccination: 38 years) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. Patient did not receive any other vaccines in 4 weeks. Patient did not receive other medications in 2 weeks. The patient was sensitive to estrogen birth controls. The patient experienced 9 days later after second dose, severe chest pain returned and full body and full body pains and aches, rheumatologist diagnosed as post viral immune syndrome related to covid vaccine, have numbness in left arm, slow reflexes, and ongoing pain in chest/neck and back on 07Apr2021. It was reported that 9 days later after second dose, severe chest pain returned and full body pains and aches. Rheumatologist diagnosed as post viral immune syndrome related to covid vaccine. Have numbness in left arm/slow reflexes and ongoing pain in chest/neck and back. Adverse events resulted in: Emergency room/department or urgent care. 2x physical therapy was given as treatment for the events. Patient did not have COVID prior vaccination. COVID tests post vaccination was unknown. The outcome of the events was not recovered.  Follow-up (23Aug2021): Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Chest pain, Hypoaesthesia, Hyporeflexia, Neck pain
Clinical narrative: 9 days later after second dose, severe chest pain returned and full body; and full body pains and aches.; Rheumatologist diagnosed as post viral immune syndrome related to covid vaccine.; Have numbness in left arm; slow reflexes; and ongoing pain in chest/neck and back; and ongoing pain in chest/neck and back; This is a spontaneous report from a contactable consumer (Patient). A 38-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8735), dose 2 via an unspecified route of administration, administered in Arm Left on 29Mar2021 (Age at vaccination: 38 years) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. Patient did not receive any other vaccines in 4 weeks. Patient did not receive other medications in 2 weeks. The patient was sensitive to estrogen birth controls. The patient experienced 9 days later after second dose, severe chest pain returned and full body and full body pains and aches, rheumatologist diagnosed as post viral immune syndrome related to covid vaccine, have numbness in left arm, slow reflexes, and ongoing pain in chest/neck and back on 07Apr2021. It was reported that 9 days later after second dose, severe chest pain returned and full body pains and aches. Rheumatologist diagnosed as post viral immune syndrome related to covid vaccine. Have numbness in left arm/slow reflexes and ongoing pain in chest/neck and back. Adverse events resulted in: Emergency room/department or urgent care. 2x physical therapy was given as treatment for the events. Patient did not have COVID prior vaccination. COVID tests post vaccination was unknown. The outcome of the events was not recovered.  Follow-up (23Aug2021): Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Viral infection
Clinical narrative: 9 days later after second dose, severe chest pain returned and full body; and full body pains and aches.; Rheumatologist diagnosed as post viral immune syndrome related to covid vaccine.; Have numbness in left arm; slow reflexes; and ongoing pain in chest/neck and back; and ongoing pain in chest/neck and back; This is a spontaneous report from a contactable consumer (Patient). A 38-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8735), dose 2 via an unspecified route of administration, administered in Arm Left on 29Mar2021 (Age at vaccination: 38 years) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. Patient did not receive any other vaccines in 4 weeks. Patient did not receive other medications in 2 weeks. The patient was sensitive to estrogen birth controls. The patient experienced 9 days later after second dose, severe chest pain returned and full body and full body pains and aches, rheumatologist diagnosed as post viral immune syndrome related to covid vaccine, have numbness in left arm, slow reflexes, and ongoing pain in chest/neck and back on 07Apr2021. It was reported that 9 days later after second dose, severe chest pain returned and full body pains and aches. Rheumatologist diagnosed as post viral immune syndrome related to covid vaccine. Have numbness in left arm/slow reflexes and ongoing pain in chest/neck and back. Adverse events resulted in: Emergency room/department or urgent care. 2x physical therapy was given as treatment for the events. Patient did not have COVID prior vaccination. COVID tests post vaccination was unknown. The outcome of the events was not recovered.  Follow-up (23Aug2021): Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: FLUA3, FLUA4
Symptoms: Pain, Pain in extremity, Paraesthesia, X-ray
Clinical narrative: Tingling, shooting, sharp pain in arm; Tingling, shooting, sharp pain in arm; Tingling, shooting, sharp pain in arm; This spontaneous case was retrieved on 09-Aug-2021 from Vaccine Adverse Event Reporting System (reference number: 1484697-1), reported by other health professional and concerned a 66-year-old, female patient.  The patient's medical history and concomitant medications were not reported.  On 05-Oct-2020, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59; dose reported as one, , route of administration: injection, anatomical location: left arm and indication: not reported). The batch number reported was 279802.  On 12-Oct-2020, seven days after receiving Fluad Quadrivalent, the patient experienced tingling, shooting and sharp pain in her arm.  On an unspecified date, the patient visited physician's office due to the events and X-ray was performed, but the results were not provided.  At the time of initial reporting, the patient had not recovered from the events.  The reporter did not provide a causality assessment to Fluad Quadrivalent, but reported that the patient assessed shooting, sharp pain in her arm as related to this vaccine. The Doctor of Medicine (MD) gave the patient multiple other diagnoses, but the patient insisted that the pain was from vaccine.  The case was assessed as non-serious.  Company comment: A 66-year-old, female patient developed tingling, shooting and pain in extremity seven days after vaccination with the suspect product Fluad Quadrivalent. Information regarding the underlying medical history and concomitant medications have not been provided. X-ray was performed, however results have not been provided. Based on provided time relationship, causality for the reported events is assessed as possibly related.; Reporter's Comments: The Doctor of Medicine (MD) gave the patient multiple other diagnoses, but the patient insisted that the pain was from vaccine.; Sender's Comments: A 66-year-old, female patient developed tingling, shooting and pain in extremity seven days after vaccination with the suspect product Fluad Quadrivalent. Information regarding the underlying medical history and concomitant medications have not been provided. X-ray was performed, however results have not been provided. Based on provided time relationship, causality for the reported events is assessed as possibly related.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Cerebral haemorrhage, Cerebral venous sinus thrombosis, Computerised tomogram head abnormal, Headache
Clinical narrative: On Sunday, July 18, 2021 patient started experiencing bad headaches and on Saturday, July 24, 2021 had two seizures followed by a major right side  stroke Causing left-sided paralysis  with brain swelling right side And blood clot.  Initially patient was taken to hospital and from there went to different Hospital where he Had emergency surgery for brain swelling and blood clot and was hospitalized in ICU for three weeks. He is currently at rehab institute where he will be for a long time.